Evelo Biosciences Inc (NASDAQ:EVLO)
| 11.57 Delayed Data As of 3:59pm ET |  -0.49 / -4.06%Today’s Change | 3.01 Today|||52-Week Range 19.93 | -4.30% Year-to-Date |
Latest EVLO News | Press Releases
No recent news for Evelo Biosciences Inc.
Today’s Trading
| Previous close | 12.06 |
| Today’s open | 12.03 |
| Day’s range | 11.51 - 12.14 |
| Volume | 6,749 |
| Average volume (3 months) | 322,639 |
| Market cap | $637.5M |
Data as of 3:59pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | +4.15% |
| Earnings growth (this year) | +21.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XENEXenon Pharmaceutical... | +2.18 | +12.17% |
| SVASinovac Biotech Ltd | -- | -- |
| ---- | ||
| AFMDAffimed NV | -0.24 | -4.06% |
Data as of 3:59pm ET, 03/02/2021
Financials
| Last reporting date | March 2, 2021 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$85.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
